See our current projects: Dr. Ewelina Perdas has been awarded the Bekker NAWA Program scholarship! We are pleased to announce that Ewelina Perdas, PhD, from our Department, has become one of the 114 laureates of Predictive Potential of Circulating MicroRNA Biomarkers in Patients with High Familial or Genetic Risk of Cancer In Poland, breast cancer poses an alarming health issue, affecting nearly 20,000 women annually. It is the second most common The non-commercial clinical trial BOOSTER has received a funding recommendation from ABM! We are delighted to inform you that the clinical research project led by Dr Anna Matyjek, a nephrology specialist from The Gray Foundation Grant – next international project in our Department! Breast cancer is the most common cancer in women. In 2020, 2.3 million new cases were diagnosed, accounting for 11.7% NCN Grant awarded to Dr. Monika Anna Golińska for endometriosis and ovarian cancer research. We are excited to share that Dr. Monika Anna Golińska has been awarded the NCN "MSCA POLONEZ BIS 3" grant Importance of the NUDT16L1-TP53BP1-TP53 axis in obesity and type 2 diabetes Obesity is one of the main risk factors for the development of type 2 diabetes as it leads to excessive Decoding “metabolic memory” – how do glycemic control and variability affect epigenetic changes in young people with type 1 diabetes? Type 1 diabetes (T1D) is the most common metabolic disease in childhood. It is caused by the destruction of pancreatic Screening for mobilization failure during hematopoietic stem cell transplantation through non-coding RNA profiling. Transplantation of hematopoietic stem cells from bone marrow is a widely used method for treating various diseases, such as blood The role of proinsulin C-peptide and G-protein coupled receptor 146 (GPR146) – clinical observation of their signaling pathway’s impact on... The project aims to investigate the role of proinsulin C-peptide and G-protein coupled receptor 146 (GPR146) in type 2 diabetes Intrinsic tumour radiosensitivity as a marker of chemoradiotherapy-induced immunogenic effects in rectal cancer Colorectal cancer (CRC) is the second leading cause of cancer death in the world. Standard treatment of patients with locally « Previous 1 2 3 4 Next »
